STOCK TITAN
  1. Home
  2. Sec-filings
  3. VOR
  4. [8-K] Vor Biopharma Inc. Reports Material Event

[8-K] Vor Biopharma Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock VOR logo
Vor Biopharma Inc.

NASDAQ:VOR

VOR Rankings

#6537 Ranked by Market Cap
N/A Ranked by Dividends

VOR Latest News

Jul 21, 2025
Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors
Jul 18, 2025
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jul 17, 2025
Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer
Jul 10, 2025
Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer
Jul 1, 2025
Vor Bio Report Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

VOR Latest SEC Filings

Jul 18, 2025
[Form 4] Vor Biopharma Inc. Insider Trading Activity
Jul 18, 2025
[Form 4] Vor Biopharma Inc. Insider Trading Activity
Jul 18, 2025
[Form 3] Vor Biopharma Inc. Initial Statement of Beneficial Ownership
Jul 18, 2025
[Form 3] Vor Biopharma Inc. Initial Statement of Beneficial Ownership
Jul 16, 2025
[144] Vor Biopharma Inc. SEC Filing

VOR Stock Data

280.53M
71.23M
32.03%
49.54%
1.17%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
CAMBRIDGE